57 related articles for article (PubMed ID: 6381211)
21. Murine model of Kawasaki disease induced by mannoprotein-beta-glucan complex, CAWS, obtained from Candida albicans.
Ohno N
Jpn J Infect Dis; 2004 Oct; 57(5):S9-10. PubMed ID: 15507772
[TBL] [Abstract][Full Text] [Related]
22. Preventative and therapeutic vaccines for fungal infections: from concept to implementation.
Deepe GS
Expert Rev Vaccines; 2004 Dec; 3(6):701-9. PubMed ID: 15606355
[TBL] [Abstract][Full Text] [Related]
23. Specific and nonspecific immunomodulation by wall components of Candida albicans.
Domer JE
J Chemother; 1989 Jul; 1(4 Suppl):441-3. PubMed ID: 16312478
[No Abstract] [Full Text] [Related]
24. Cytokine response to inactivated Candida albicans in mice.
Rosati E; Scaringi L; Cornacchione P; Fettucciari K; Sabatini R; Rossi R; Marconi P
Cell Immunol; 1995 May; 162(2):256-64. PubMed ID: 7743553
[TBL] [Abstract][Full Text] [Related]
25. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice.
MacCallum DM; Odds FC
Mycoses; 2005 May; 48(3):151-61. PubMed ID: 15842329
[TBL] [Abstract][Full Text] [Related]
26. Induced resistance to Candida albicans in BALB/c mice during short-term immunosuppression with cyclophosphamide.
van Wyk CW; van der Bijl P; Cooper RC
Lab Anim Sci; 1995 Feb; 45(1):101-6. PubMed ID: 7752605
[No Abstract] [Full Text] [Related]
27. Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells.
Yang YL; Wang CW; Chen CT; Wang MH; Hsiao CF; Lo HJ
Mycol Res; 2009 Mar; 113(Pt 3):388-90. PubMed ID: 19111931
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow colony-formation in vitro after infection of genetically defined inbred mice with Candida albicans.
Wanasaengsakul S; Ashman RB
Microb Pathog; 2004 Apr; 36(4):211-7. PubMed ID: 15001227
[TBL] [Abstract][Full Text] [Related]
29. Role of adaptive immunity in the pathogenesis of Candida albicans keratitis.
Zhang H; Chen H; Niu J; Wang Y; Xie L
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2653-9. PubMed ID: 19218608
[TBL] [Abstract][Full Text] [Related]
30. Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida -induced production of cytokines.
Villamón E; Gozalbo D; Roig P; Murciano C; O'Connor JE; Fradelizi D; Gil ML
Eur Cytokine Netw; 2004; 15(3):263-71. PubMed ID: 15542452
[TBL] [Abstract][Full Text] [Related]
31. Lymphoid cell surface receptor for Moloney leukemia virus envelope glycoprotein gp71. I. Binding characteristics.
Choppin J; Schaffar-Deshayes L; Debré P; Lévy JP
J Immunol; 1981 Jun; 126(6):2347-51. PubMed ID: 7229379
[TBL] [Abstract][Full Text] [Related]
32. Enhanced resistance against systemic Candida albicans infection in mice treated with C. albicans DNA.
Dimitrova P; Yordanov M; Danova S; Ivanovska N
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):231-6. PubMed ID: 18507679
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic heterogeneity of Moloney leukemia virus-induced T cel lymphomas.
Pepersack L; Lee JC; McEwan R; Ihle JN
J Immunol; 1980 Jan; 124(1):279-85. PubMed ID: 6965293
[No Abstract] [Full Text] [Related]
34. [The influence of intensity of Trichinella invasion on the phagocytosis of Candida albicans by mice macrophages].
Szkudlinski J
Wiad Parazytol; 2001; 47(4):661-6. PubMed ID: 16886407
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor-alpha secretion by splenocytes of Candida albicans infected mice.
Vecchiarelli A; Puliti M; Blasi E; Bistoni F
J Chemother; 1989 Jul; 1(4 Suppl):1170-1. PubMed ID: 16312819
[No Abstract] [Full Text] [Related]
36. [Immunomodulation by inactivated Candida albicans].
Bistoni F; Marconi P; Cassone A; Frati L
G Ital Chemioter; 1985; 32(1):147-52. PubMed ID: 3913614
[No Abstract] [Full Text] [Related]
37. Fungal ribosomal vaccines. I. Histoplasma and Candida vaccines.
Segal E
Mycopathologia; 1989 Jan; 105(1):45-8. PubMed ID: 2662009
[No Abstract] [Full Text] [Related]
38. Cellular response to Candida albicans after intraperitoneal injection to non-immunized and immunized mice and rabbits.
Kuttin ES; Müller J; Vogt A
Mykosen; 1984 Apr; 27(4):175-84. PubMed ID: 6374447
[No Abstract] [Full Text] [Related]
39. [Clinical application of fungus extracts and its culture filtrate in the treatment of skin diseases; (3) Candida vaccine in the treatment of warts (author's transl)].
Harada S
Nihon Hifuka Gakkai Zasshi; 1979 May; 89(6):397-402. PubMed ID: 315481
[No Abstract] [Full Text] [Related]
40. The role of the peritoneal cavity in successful treatment of a murine lymphoma with chemotherapy and non-specific immunostimulation.
Marconi P; Bistoni F; Cassone A; Frati L; Baccarini M; Garaci E; Bonmassar E
Cancer Immunol Immunother; 1982; 13(2):128-33. PubMed ID: 6760959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
